Pilot Investigation of Stem Cells in Stroke Phase II Efficacy

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

August 16, 2017

Conditions
Ischaemic StrokeCerebral InfarctionHemiparesisArm Paralysis
Interventions
BIOLOGICAL

CTX DP

20 million cell dose administered by surgery to the damaged area of the brain

Trial Locations (9)

Unknown

Queen Elizabeth Hospital, Birmingham

Kings College Hospital, London

University College London Hospital, London

Royal Victoria Infirmary, Newcastle

Nottingham City Hospital, Nottingham

SalfordRoyal NHS Foundation Trust, Salford

Royal Hallamshire Hosptial, Sheffield

Southampton Hospital, Southampton

G51 4TF

NHS Southern General Hospital, Glasgow

All Listed Sponsors
lead

ReNeuron Limited

INDUSTRY

NCT02117635 - Pilot Investigation of Stem Cells in Stroke Phase II Efficacy | Biotech Hunter | Biotech Hunter